Belvin Marcia (CIK 0001970752)

Latest company ownership

CTMX - CytomX Therapeutics, Inc.

Role: SVP, Chief Scientific Officer

Shares held

18,150

Last filed at

Sep 30, 2025

Confidence Score

49.8

2025Q4

Confidence Score History

2023Q3 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Jun 13, 2025	Jun 17, 2025	CytomX Therapeutics, Inc.	SVP, Chief Scientific Officer	Sell	46.3	-13,884	-4.85%	✗	$37.3K
Mar 18, 2025	Mar 20, 2025	CytomX Therapeutics, Inc.	SVP, Chief Scientific Officer	Sell	46.3	-19,512	-7.28%	✗	$11.7K
Aug 20, 2024	Aug 22, 2024	CytomX Therapeutics, Inc.	SVP, Chief Scientific Officer	Sell	47.5	-4,181	-2.32%	✗	$5.1K
Mar 19, 2024	Mar 21, 2024	CytomX Therapeutics, Inc.	SVP, Chief Scientific Officer	Sell	46.3	-12,795	-7.05%	✗	$26.7K
Dec 20, 2023	Dec 22, 2023	CytomX Therapeutics, Inc.	SVP, Chief Scientific Officer	Sell	47.5	-4,077	-2.56%	✗	$5.6K
Sep 20, 2023	Sep 22, 2023	CytomX Therapeutics, Inc.	SVP, Chief Scientific Officer	Sell	85.0	+7,131	5.06%	✗	$5.4K